Alcresta Secures $10,000,000 Series B Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    One Newton Executive Park Newton, MA 02462
  • Company Description
    Alcresta is developing and commercializing innovative enzyme-based nutritional products that improve patient health and manage disease for infants, older adults and patients battling acute or chronic conditions.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Funds will be used to continue to advance regulatory filings, commercial planning and preparations for the expected 2014 launch of the company’s lead nutritional product.
  • M&A Terms
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Third Rock Ventures